Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC10A1 | Q14973 | 20/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22511164 | 0.91 | SLC10A1 (0.58) | SLC10A1 | |
| SCHEMBL21890573 | 0.91 | SLC10A1 (0.69) | SLC10A1 | |
| SCHEMBL22511167 | 0.89 | SLC10A1 (0.68) | SLC10A1 | |
| SCHEMBL21889975 | 0.88 | SLC10A1 (0.61) | SLC10A1 | |
| SCHEMBL21889971 | 0.87 | SLC10A1 (0.66) | SLC10A1 | |
| SCHEMBL21890556 | 0.86 | SLC10A1 (0.65) | SLC10A1 | |
| SCHEMBL21889978 | 0.86 | SLC10A1 (0.65) | SLC10A1 | |
| SCHEMBL21890557 | 0.84 | SLC10A1 (0.73) | SLC10A1 | |
| SCHEMBL22528159 | 0.84 | SLC10A1 (0.78) | SLC10A1 | |
| SCHEMBL22545559 | 0.84 | SLC10A1 (0.78) | SLC10A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4733305-A2 | PYRROLE COMPOUNDS | Aligos Therapeutics, Inc. (US) | 2026-04-29 | — | — | EP | disclosed |
| US-12599582-B2 | Pyrrole compounds | ALIGOS THERAPEUTICS, INC. (US) | 2026-04-14 | — | — | US | disclosed |
| EP-3947349-B1 | PYRROLE COMPOUNDS | ALIGOS THERAPEUTICS INC (US) | 2026-03-11 | — | — | EP | disclosed |
| US-20230390242-A1 | PYRROLE COMPOUNDS | ALIGOS THERAPEUTICS, INC. | 2023-12-07 | — | — | US | disclosed |
| US-11771680-B2 | Pyrrole compounds | ALIGOS THERAPEUTICS, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-11771680-B2 | Pyrrole compounds | ALIGOS THERAPEUTICS, INC. (US) | 2023-10-03 | — | — | US | disclosed |
| US-20230056135-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | EMORY UNIVERSITY (US) | 2023-02-23 | — | — | US | disclosed |
| US-20220071957-A1 | PYRROLE COMPOUNDS | EMORY UNIVERSITY | 2022-03-10 | — | — | US | disclosed |
| US-11191747-B2 | Pyrrole compounds | ALIGOS THERAPEUTICS, INC. (US) | 2021-12-07 | — | — | US | disclosed |
| US-11191747-B2 | Pyrrole compounds | ALIGOS THERAPEUTICS, INC. (US) | 2021-12-07 | — | — | US | disclosed |
| US-20200323821-A1 | PYRROLE COMPOUNDS | EMORY UNIVERSITY | 2020-10-15 | — | — | US | disclosed |
| US-20200323821-A1 | PYRROLE COMPOUNDS | EMORY UNIVERSITY | 2020-10-15 | — | — | US | disclosed |
| WO-2020205934-A1 | PYRROLE COMPOUNDS | ALIGOS THERAPEUTICS, INC. (US) | 2020-10-08 | — | — | WO | disclosed |
| WO-2020072955-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | EMORY UNIVERSITY (US) | 2020-04-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230390242-A1 | PYRROLE COMPOUNDS | PKD1, ADCYAP1R1, PYCR1 | SLC10A1 48/4885 |
| US-12599582-B2 | Pyrrole compounds | PEF1, CYP4F8, CYP2C19 | SLC10A1 74/4885 |
| US-20230056135-A1 | MONOMER AND MULTIMERIC ANTI-HBV AGENTS | HAVCR2, HMBS, HDGF | SLC10A1 8/4885 |
| US-11771680-B2 | Pyrrole compounds | PKD1, ADCYAP1R1, PYCR1 | SLC10A1 48/4885 |
| US-20200323821-A1 | PYRROLE COMPOUNDS | PKD1, ADCYAP1R1, PYCR1 | SLC10A1 48/4885 |
| US-20220071957-A1 | PYRROLE COMPOUNDS | PKD1, ADCYAP1R1, PYCR1 | SLC10A1 48/4885 |
| US-11191747-B2 | Pyrrole compounds | PKD1, ADCYAP1R1, PYCR1 | SLC10A1 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.